These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 15451770

  • 1. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
    Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prins MH, Van Der Meer J, Büller HR.
    Arch Intern Med; 2004 Sep 27; 164(17):1932-7. PubMed ID: 15451770
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
    Couturaud F, Kearon C, Leroyer C, Mercier B, Abgrall JF, Le Gal G, Lacut K, Oger E, Bressollette L, Ferec C, Lamure M, Mottier D, Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).
    Thromb Haemost; 2006 Dec 27; 96(6):744-9. PubMed ID: 17139368
    [Abstract] [Full Text] [Related]

  • 4. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.
    Haematologica; 2008 May 27; 93(5):729-34. PubMed ID: 18387978
    [Abstract] [Full Text] [Related]

  • 5. Venous thrombotic risk in family members of unselected individuals with factor V Leiden.
    Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR.
    Thromb Haemost; 2000 Jun 27; 83(6):817-21. PubMed ID: 10896231
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.
    De Stefano V, Rossi E, Paciaroni K, D'Orazio A, Cina G, Marchitelli E, Pepe R, Leone G.
    Haematologica; 2003 Jan 27; 88(1):61-6. PubMed ID: 12551828
    [Abstract] [Full Text] [Related]

  • 8. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
    Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H.
    Thromb Haemost; 1999 May 27; 81(5):684-9. PubMed ID: 10365737
    [Abstract] [Full Text] [Related]

  • 9. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group.
    Circulation; 2005 Nov 29; 112(22):3495-500. PubMed ID: 16301339
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients.
    Leroyer C, Mercier B, Oger E, Chenu E, Abgrall JF, Férec C, Mottier D.
    Thromb Haemost; 1998 Jul 29; 80(1):49-51. PubMed ID: 9684784
    [Abstract] [Full Text] [Related]

  • 11. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.
    Thromb Res; 2008 Jul 29; 121(6):743-50. PubMed ID: 17804043
    [Abstract] [Full Text] [Related]

  • 12. Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation.
    Navarro S, Medina P, Mira Y, Estellés A, Villa P, Ferrando F, Vayá A, Bertina RM, España F.
    Haematologica; 2008 Jun 29; 93(6):885-91. PubMed ID: 18403391
    [Abstract] [Full Text] [Related]

  • 13. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E, Lacut K, Le Gal G, Couturaud F, Abalain JH, Mercier B, Mottier D, EDITH (Etude des Déterminants/Interaction de la THrombose veineuse) Collaborative Study Group.
    Thromb Res; 2007 Jun 29; 120(2):207-14. PubMed ID: 17126889
    [Abstract] [Full Text] [Related]

  • 14. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
    De Stefano V, Martinelli I, Rossi E, Battaglioli T, Za T, Mannuccio Mannucci P, Leone G.
    Br J Haematol; 2006 Nov 29; 135(3):386-91. PubMed ID: 16984390
    [Abstract] [Full Text] [Related]

  • 15. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F.
    Thromb Haemost; 1999 Nov 29; 82(5):1395-8. PubMed ID: 10595625
    [Abstract] [Full Text] [Related]

  • 16. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G, Wenstrom K, Samuels P, Cotroneo MA, Moawad A, Sorokin Y, Meis P, Miodovnik M, O'Sullivan MJ, Conway D, Wapner RJ, Gabbe SG, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Obstet Gynecol; 2005 Sep 29; 106(3):517-24. PubMed ID: 16135581
    [Abstract] [Full Text] [Related]

  • 17. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.
    Rossi E, Ciminello A, Za T, Betti S, Leone G, De Stefano V.
    Thromb Haemost; 2011 Oct 29; 106(4):646-54. PubMed ID: 21833444
    [Abstract] [Full Text] [Related]

  • 18. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].
    Samama MM, Rached RA, Conard J, Horellou MH, Elalamy I.
    Bull Acad Natl Med; 2004 Oct 29; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665
    [Abstract] [Full Text] [Related]

  • 19. [The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results].
    Schramm W, Heinemann LA, Spannagl M, Dick A, Assmann A.
    Dtsch Med Wochenschr; 2000 Jan 07; 125(1-2):2-6. PubMed ID: 10650817
    [Abstract] [Full Text] [Related]

  • 20. The first homozygous family for prothrombin G20210A polymorphism reported in Latin America.
    Roman-Gonzalez A, Cardona H, Cardona-Maya W, Alvarez L, Castaneda S, Martinez J, Torres JD, Tobon L, Bedoya G, Cadavid A.
    Clin Appl Thromb Hemost; 2009 Feb 07; 15(1):113-6. PubMed ID: 18829602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.